Laparoskopik Kolesistektomi’de 5 Yıllık Deneyimimiz

Yıl 2009, Cilt: 3 Sayı: 3, 137 - 140, 11.11.2009

Ahmet Serdar Karaca

Öz

ÖZET Bu çalışmada, bir devlet hastanesi genel cerrahi kliniğinde laparoskopik kolesistektomi deki 5 yıllık deneyimi belirlemek amaçlanmıştır. Ocak 2005 ve Haziran 2009 yılları arasında, laparoskopik kolesistektomi uygulanan 672 hasta incelendi. Yaş, cinsiyet, erken ve geç komplikasyon oranları, laparoskopik kolesistektomiden açığa geçiş oranları, geçiş nedenleri saptandı. Ocak-2005
ve Haziran-2009 yılları arasında 672 hastaya laparoskopik kolesistektomi uygulandı. 594 hasta kronik kolesistit (%88.3), 48 hasta akut kolesistit (%7.1), 30 hasta safra kesesi polibi (%4.4) tanısına sahipti. 46 hastaya mekanik ikter nedeniyle ERCP yapıldı. Açık cerrahiye dönüş oranı % 3.5 idi (24/672). Calot üçgeninin disseksiyonundaki zorluk ve farklı anatomi açık cerrahi tekniğe dönüşün
ana sebebi idi. Mortalite oranı %0, morbidite oranı %7.7 (52/672) şeklinde gerçekleşti. Dört olguda insizyonel fıtık, 41 olguda ameliyat esnasında kese perforasyonu oldu (%7.1). 7 vakada ciltaltı enfeksiyon gelişti. Kolesistektomi, açık ya da laparoskopik yöntemle kurallara uyulmak koşulu ile güvenle uygulanabilir.

Anahtar Kelimeler

Laparoskopik kolesistektomi, komplikasyonlar, genel cerrahi

Kaynakça

• 1. Yang MT, Rong TH, Huang ZF et al, Clinical analysis of resectable breast cancer: a report of 6 263 cases. Ai Zheng 2005;24(3):327-31.
• 2. Leinung S, Schönfelder M, Winzer KJ et al, Wound infection and infection-promoting factors in breast cancer surgery -- a prospectivemulticenter study on quality control. Zentralbl Chir 2005;130(1):16-20.
• 3. Vitug AF, Newman LA, Complications in breast surgery. Surg Clin North Am 2007;87(2): 431-51. 4. Kompatscher P, von Planta A, Spicher I et al. Comparison of the incidence and predicted risk of early surgical site infections after breast reduction. Aesthetic Plast Surg 2003;27(4): 308-14.
• 5. Barber GR, Miransky J, Brown AE et al. Direct observations of surgical wound infections at a comprehensive cancer center. Arch Surg 1995;130(10):1042-7.
• 6. Sørensen LT, Hørby J, Friis E, Pilsgaard B, Jørgensen T. Smoking as a risk factor for wound healing and infection in breast cancer surgery. Eur J Surg Oncol 2003;29(5):482.
• 7. Gamboa-Bobadilla GM, Killingsworth C. Large-volume reduction mammaplasty: the effect of body mass index on postoperative complications. Ann Plast Surg 2007;58(3):246-9.
• 8. Nicolas P, Yazdan Y, Marie-Pierre C,et al. Prevention of surgical site infection after breast cancer surgery by targeted prophylaxis antibiotic in patients at high risk of surgical site infection. J Surg Oncol 2007;96(2):124-9.
• 9. Lefebvre D, Penel N, Deberles MF, Fournier C. Incidence and surgical wound infection risk factors in breast cancer surgery. Presse Med 2000;29(35):1927-32.
• 10. Denison U, Baumann J, Peters-Engl C,et al. Incidence of anaemia in breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat 2003;79(3):347-53.
• 11. Beale E, Zhu J, Chan L, Shulman I, Harwood R, Demetriades D. Blood transfusion in critically injured patients: a prospective study. Injury 2006;37(5):455-65.
• 12. Levi N,Sandberg T. Blood transfusion and postoperative wound infection in intacapsuler femoral neck fractures. Bull Hosp Jt Dis 1998;57(2):69-73.
• 13. Herman K, Kołodziejski L. Blood transfusion and survival after surgery for stage I and II breast cancer. Neoplasma 1993;40(2):117-25.
• 14. Tartter PI, Burrows L, Papatestas AE, Lesnick G, Aufses AH Jr. Perioperative blood transfusion has prognostic significance for breast cancer. Surgery 1985;97(2):225-30.
• 15. Pysz M. Blood transfusions in breast cancer patients undergoing mastectomy: possible importance of timing. J Surg Oncol 2000;75(4): 258-63.
• 16. Shiba H, Ishida Y, Wakiyama S, et al. Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection.J Gastrointest Surg 2009;13(9):1636-42.
• 17. Dionigi G, Boni L, Rovera F, et al. Effect of perioperative blood transfusion on clinical outcomes in hepatic surgery for cancer. World J Gastroenterol 2009;15(32):3976-83.
• 18. Gerber B, Arndt M, Wesselburg C, Krause A. Responsibility for patient education and incidence of homologous blood transfusions in unilateral breast cancer operations. Geburtshilfe rauenheilkd 1995;55(10):572-6.
• 19. Arndt M, Gerber B, Wesselburg C, Krause A, Benad G. Transfusion incidence and indications for homologous blood sparing measures in single stage breast carcinoma operations. Anaesthesiol Reanim 1995;20(6):153-6.